Moreover, the administration of a let-7a mimic and an anti-IL-6 antibody has the potential to modulate the communication between radioresistant and radiosensitive cells and enhance the efficacy of radiotherapy for esophageal cancer. Here, IL6 is linked to esophageal cancer.